Nature’s Rx Issues Voluntary Nationwide Recall of Silver Bullet 10 Male Enhancement Capsules due to an Undeclared PDE-5 Inhibitor Found in The Product
Audience: Consumers
November 13, 2019 -- Nature’s Rx is voluntarily recalling lot: 01251ZX1, Expiry Date: 11/2022 of Silver Bullet (10 Male Enhancement Capsules). This recall has been initiated after an FDA laboratory analysis found the product to contain undeclared sildenafil, the active ingredient in Viagra, which is a PDE-5 inhibitor. The undeclared PDE-5 inhibitor in the product may pose serious health risks to consumers with underlying medical issues. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, or heart disease often take nitrates.
To date, Nature’s Rx has not received any reports of adverse events related to this recall.
The product, Silver Bullet (10 Male Enhancement Capsules), is used as a male enhancement nutritional supplement contained in blister foil sheets and packaged in small boxes containing 10 capsules with an expiry date: 11/2022 and lot number: 01251ZX1. Silver Bullet (10 Male Enhancement Capsules) was sold on an online website: www.naturalrx.net.
Nature’s Rx is notifying its customers by replacement or refund and is arranging for return or replacement of all recalled products. Consumers that have Silver Bullet (10 Male Enhancement Capsules), which is being recalled should stop using and return ship or discard the product.
Consumers with questions regarding this recall can contact Nature’s Rx by phone number or e-mail address 5 days of the week from 10 AM to 6 PM PST. 1-888-925-5551, email us at: naturesrxsales@gmail.com or mail us at: 310 N Indian Hill Blvd Ste 600, Claremont, CA 91711
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online
- Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Source: FDA
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.